Fewer drops. More control. Sustained eye pressure management.
iDose® TR is a micro, FDA-approved intracameral implant that continuously releases a targeted dose of medication directly inside your eye for up to 4 years. Unlike eye drops that rely on patient compliance, iDose TR delivers steady pressure control 24/7—simplifying your routine and reducing vision-threatening fluctuations.
Your eye will be numb, but you’ll be comfortable throughout the procedure.
A eye surgeon places the implant through a tiny opening inside the eye.
The implant releases medication over time to help control IOP.
Routine visits track pressure and healing.
Not all patients are candidates for iDose. Only an eye care professional can diagnose glaucoma and recommend appropriate treatment. Individual results vary. Always follow your doctor’s instructions and attend scheduled follow-ups. iDose may help reduce the number of daily drops for many patients but does not eliminate drop use for everyone.
You may be a candidate if you:
Your eye surgeon will consider glaucoma type, optic nerve status, target pressure, prior surgeries, current meds, and overall health before recommending a plan.
Daily use of medicated drops lowers eye pressure.
Pros: Widely available, non-surgical, customizable combinations.
Cons: Difficult for many patients to remember consistently, may cause burning, redness, or systemic side effects. Non-adherence is one of the leading causes of glaucoma progression.
Uses laser energy to improve fluid drainage in the eye.
Pros: Quick, in-office procedure; can delay or reduce the need for drops.
Cons: Results may wear off over time; some patients still require drops or repeat treatments.
Small surgical implants or procedures improve eye fluid outflow.
Pros: Can be done with cataract surgery; effective for certain glaucoma stages.
Cons: Typically suited for mild to moderate glaucoma; still evolving in long-term outcomes.
A tiny implant placed inside the eye releases medication continuously over months to years, reducing IOP without daily drops.
Pros: Long-term, consistent drug delivery; reduces or eliminates the need for drops; bypasses adherence issues; can be replaced when needed.
Cons: Requires a quick, in-office procedure; as with all implants, carries a small risk of surgical complications.
Daily use of medicated drops lowers eye pressure.
Pros: Widely available, non-surgical, customizable combinations.
Cons: Difficult for many patients to remember consistently, may cause burning, redness, or systemic side effects. Non-adherence is one of the leading causes of glaucoma progression.
Uses laser energy to improve fluid drainage in the eye.
Pros: Quick, in-office procedure; can delay or reduce the need for drops.
Cons: Results may wear off over time; some patients still require drops or repeat treatments.
Small surgical implants or procedures improve eye fluid outflow.
Pros: Can be done with cataract surgery; effective for certain glaucoma stages.
Cons: Typically suited for mild to moderate glaucoma; still evolving in long-term outcomes.
A tiny implant placed inside the eye releases medication continuously over months to years, reducing IOP without daily drops.
Pros: Long-term, consistent drug delivery; reduces or eliminates the need for drops; bypasses adherence issues; can be replaced when needed.
Cons: Requires a quick, in-office procedure; as with all implants, carries a small risk of surgical complications.
Many patients use significantly fewer drops after iDose, but some will still need additional medication. Your plan is personalized.
iDose® TR is designed for long-duration, continuous medication delivery. In clinical studies, about 8 out of 10 patients were drop-free 12 months after receiving the implant, with ongoing monitoring to ensure pressure stays on target. Glaukos iDose® TR Additional peer-reviewed data show durable IOP lowering and a reduced need for topical medications for 36 months after a single implant, though results vary by patient. Your specialist will track your eye pressure over time and discuss if/when a replacement implant or adjunct drops are appropriate
Yes, iDose can be placed independently or alongside cataract surgery in appropriate patients.
All procedures carry risks, such as temporary irritation, inflammation, pressure fluctuations, or the need for additional treatment. Your surgeon will review the benefits and risks for your eyes.
Most patients resume light activities quickly, following protection and care instructions.
4800 N. 22nd St.
Phoenix, AZ 85016
